LakeShore Biopharma regains ompliance with Nasdaq minimum bid price requirement
The Fly

LakeShore Biopharma regains ompliance with Nasdaq minimum bid price requirement

LakeShore Biopharma (LSB) has received a written notice from the Nasdaq Listing Qualifications Department informing the company that it has regained compliance with the minimum bid price requirement. According to the compliance notice, the company regained compliance with the Minimum Bid Price Requirement because the closing bid price of the company’s ordinary shares have been $1.00 per share or greater for 11 consecutive business days, from October 4 to October 18, and the matter is now closed.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App